San Jose, CA, United States of America

Ian Quang Chau

This inventor holds 1 USPTO granted patent. Top assignee: Roche Sequencing Solutions, Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ian Quang Chau. Retrieved from https://idiyas.com/inventor/ian-quang-chau

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ian Quang Chau: Innovator in Sequencing Technology

Introduction

Ian Quang Chau is a notable inventor based in San Jose, California. He has made significant contributions to the field of sequencing technology, particularly through his innovative methods for labeling target molecules.

Latest Patents

Ian holds a patent titled "Method for labeling of aldehyde containing target molecules." This invention focuses on enhancing the processing rate of sequencing reactions, specifically in nanopore sequencing. The method utilizes improved nucleoside-tags that are linked to nucleoside phosphate via a Pictet Spengler reaction. This advancement is particularly beneficial for nanopore-based nucleic acid sequencing-by-synthesis reactions.

Career Highlights

Ian Quang Chau is currently employed at Roche Sequencing Solutions, Inc., where he continues to develop cutting-edge technologies in the field of genomics. His work is instrumental in advancing the capabilities of sequencing technologies, which have far-reaching implications in research and medicine.

Collaborations

Ian collaborates with esteemed colleagues such as Frank Bergmann and Peter Crisalli, contributing to a dynamic and innovative work environment.

Conclusion

Ian Quang Chau's contributions to sequencing technology exemplify the impact of innovative thinking in scientific research. His patent and ongoing work at Roche Sequencing Solutions, Inc. highlight his role as a key player in the advancement of genomic technologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…